Nucleotide analogs for efficient DNA and RNA amplification

Inventors

Benner, Steven AYang, ZunyiKim, Myong Jung

Assignees

FIREBIRD DIAGNOTICSFOUNDATION FOR APPLIED MOLECULAR EVOLUTION, INC.

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12460256-B1

Patent

Publication Date

2025-11-04

Expiration Date


Abstract

This invention covers processes that amplify multiple DNA and RNA targets, solving the “multiplexed PCR problem”, as well as supporting isothermal amplification and delivering other capabilities in multiplexed molecular analysis. It uses inventive DNA analogs.

Core Innovation

The invention provides a process for extending an oligonucleotide analog primer by template-directed polymerization. A template oligonucleotide having a portion substantially complementary to the oligonucleotide analog primer is contacted in aqueous solution with a DNA polymerase, an RNA polymerase, and/or a reverse transcriptase, and nucleoside triphosphates. The resulting mixture is incubated for a preselected time and a preselected temperature, and one or more nucleotide units in the oligonucleotide analog primer have, instead of a standard nucleobase, a substituted heterocycle structure integrated into the primer.

The substituted heterocycle is defined by an alkynyl or alkenyl linker, where Z attached to the alkynyl or alkenyl linker is H, CH3, an alkyl group, or an alkyl group carrying a tag, and R is the point of attachment to the remainder of the oligonucleotide analog primer. The document describes MODURA self-avoiding nucleotide analogs and emphasizes improved behavior in multiplexed DNA/RNA amplification by using these analogs as primer units. The improved pairing stabilizes target duplexes while preventing primer-primer interactions.

The described system is used for multiplexed DNA/RNA amplification, including PCR and isothermal amplification approaches, with examples including RT-PCR and recombinase polymerase amplification (RPA). The report indicates that the selected MODURA base analogs delay primer dimer formation and reduce off-target amplification while maintaining amplification performance. Documented characterization includes melting curve behavior, including sharp melting peaks for on-target performance, and reduced off-target Ct shifts in multiplex contexts.

Claims Coverage

The independent claim covers template-directed polymerization extension of an oligonucleotide analog primer containing substituted heterocycles (MODURA/self-avoiding units) under aqueous conditions with polymerase activity and nucleoside triphosphates. The claim includes several inventive refinements across dependent claims focused on heterocycle substituent selection, linker selection, and inclusion of additional analog primers containing selected heterocycles.

Template-directed extension of an oligonucleotide analog primer with substituted heterocycles

A process for extending an oligonucleotide analog primer by template-directed polymerization by contacting a substantially complementary template in aqueous solution with a DNA polymerase, an RNA polymerase, and/or a reverse transcriptase, and nucleoside triphosphates, followed by incubating for a preselected time and a preselected temperature, wherein one or more nucleotide units in the oligonucleotide analog primer has instead of a standard nucleobase a substituted heterocycle having an alkynyl or alkenyl linker with a defined attachment to the remainder of the primer.

Heterocycle substituent Z selection with defined linker attachment

The process further specifies that Z attached to the alkynyl or alkenyl linker is H, CH3, an alkyl group, or an alkyl group carrying a tag, where R is the point of attachment of the substituted heterocycle to the remainder of the oligonucleotide analog primer.

Primer includes at least one selected heterocycle identity

The process is characterized in that an oligonucleotide analog primer contains at least one heterocycle selected from N-methylcytosine, N-ethylcytosine, 2-aminopurine, 2,6-diaminopurine, and hypoxanthine.

Mixture includes an additional oligonucleotide analog with selected heterocycles

The process is carried out with a mixture that includes an additional oligonucleotide analog in which one or more heterocycles replace a standard nucleobase, selected from N-methylcytosine, N-ethylcytosine, 2-aminopurine, 2,6-diaminopurine, and hypoxanthine.

Across the claim set, the central coverage is extension of an oligonucleotide analog primer by template-directed polymerization in aqueous solution with polymerase activity, where the primer incorporates a substituted heterocycle defined via an alkynyl or alkenyl linker and a selectable Z substituent. Dependent claim refinements specify particular Z values and the use of particular heterocycles, including N-methylcytosine, N-ethylcytosine, 2-aminopurine, 2,6-diaminopurine, and hypoxanthine, either within the primer and/or in an additional analog contained in the mixture.

Stated Advantages

Prevents primer dimer formation.

Reduces off-target amplification.

Enables high-plex multiplex performance while maintaining amplification efficiency.

Improves on-target duplex behavior, reflected in melting curve results such as sharp melting peaks and reduced off-target Ct shifts.

Documented Applications

Multiplexed DNA/RNA amplification using MODURA self-avoiding nucleotide analogs, including multiplexed PCR and isothermal amplification.

RT-PCR.

Recombinase polymerase amplification (RPA).

Helicase-dependent amplification (HDA).

Strand displacement amplification (SDA).

Illumina next-generation sequencing.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.